Combination Treatment for Staph Infections
(SHIELD Trial)
Trial Summary
What is the purpose of this trial?
Indigenous persons experience a high burden of Staphylococcus aureus (SA) invasive disease and skin and soft tissue infections. SA carriage on the skin is factor for development of SA infections. The goal of this clinical trial is to evaluate a community-informed approach to reduce carriage of SA. Participants will be assigned to education and household supplies for prevention of SA with and without a biomedical intervention. Researchers will compare SA carriage in the two groups.
Will I have to stop taking my current medications?
The trial does not specify if you need to stop taking your current medications, but you cannot have used antibiotics in the 30 days before the study starts.
What data supports the effectiveness of the treatment for Staph infections?
How does the combination treatment for Staph infections differ from other treatments?
This treatment is unique because it combines education and household supplies to prevent Staph infections, focusing on community-based interventions like promoting handwashing with soapy water, which is cost-effective and easy to implement, unlike traditional medical treatments that often rely on antibiotics.678910
Research Team
Laura Hammitt, MD
Principal Investigator
Johns Hopkins Bloomberg School of Public Health
Eligibility Criteria
This trial is for Native American adults living near WMA Tribal lands, aged 18+, with lab-confirmed Staphylococcus aureus (SA) carriage. They must be able to consent and follow the study plan, and have either diabetes, a BMI ≥30, or past SA infections. Excluded are those who've taken antibiotics recently, currently have an SA infection, are related to the study staff, allergic to certain ingredients in the treatments or without a permanent home.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive education and household supplies, with Group A also receiving a nasal antibiotic and antiseptic regimen
Follow-up
Participants are monitored for safety and effectiveness after treatment
Treatment Details
Interventions
- Chlorhexidine gluconate
- Education + Household supplies
- Mupirocin
- Nozin
Find a Clinic Near You
Who Is Running the Clinical Trial?
Johns Hopkins Bloomberg School of Public Health
Lead Sponsor
National Institute of General Medical Sciences (NIGMS)
Collaborator